Overview

Endogenous Opioid Modulation by Ketamine

Status:
Withdrawn
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
Demonstrate the acute effects of ketamine on endogenous ยต-opioid neurotransmission in humans.
Phase:
Phase 3
Details
Lead Sponsor:
University of Utah
Treatments:
Endorphins
Ketamine